AIMS exams should be routine, even when using telemedicine, experts say ...

Tardive dyskinesia causes repeated, uncontrollable movements in the face and body. It is a side effect of some neuroleptic or antipsychotic medications. These medications may change dopamine activity ...

You may be able to reduce tardive dyskinesia with treatment. Some lifestyle behaviors, like getting enough sleep and exercise, can help. Tardive dyskinesia is a side effect of neuroleptic or ...

Nycole S. 42 of Winfield, Kansas, started her mental health journey when she was diagnosed with bipolar disorder in her teens. “When I was in high school, I was placed in a mental institution, which ...

More than half of patients with tardive dyskinesia who used valbenazine experienced symptomatic remission at 48 weeks, and ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...

Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...

Tardive dyskinesia (TD) and related drug-induced movement disorders represent a spectrum of involuntary hyperkinetic and hypokinetic syndromes arising predominantly from long-term exposure to dopamine ...

The movement disorder ADCY5-related dyskinesia can be treated with the asthma drug theophylline. This has been shown in a recent study by Martin Luther University Halle-Wittenberg (MLU), University ...

Tardive dyskinesia is a condition that can cause involuntary movements of the face, including the jaw, lips, and tongue. Although it’s less common, other parts of the body can also be affected, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Nycole was compensated by Neurocrine Biosciences, Inc. to share her story. As a result of being on those medications, Nycole developed tardive dyskinesia (TD), a condition that affects approximately ...